Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Grupos

Publicaciones

  • Matias-Guiu, X; Stewart CJR

    Endometriosis-associated ovarian neoplasia

    Pathology 50 190-204. .

    [doi:10.1016/j.pathol.2017.10.006]

  • Gatius, S; Cuevas, D; Fernandez, C; Roman-Canal, B; Adamoli, V; Piulats, JM; Eritja, N; Martin-Satue, M; Moreno-Bueno, G; Matias-Guiu, X

    Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences

    Pathobiology 85 35-40. .

    [doi:10.1159/000475529]

  • Martinez-Garcia, E; Lopez-Gil, C; Campoy, I; Vallve, J; Coll, E; Cabrera, S; Ramon Y Cajal, Santiago; Matias-Guiu, X; Van Oostrum, J; Reventos, J; Gil-Moreno, A; Colas, E

    Advances in endometrial cancer protein biomarkers for use in the clinic

    EXPERT REVIEW OF PROTEOMICS 15 81-99. .

    [doi:10.1080/14789450.2018.1410061]

  • Oaknin A.; Guarch R.; Barretina P.; Hardisson D.; González-Martín A.; Matías-Guiu X.; Pérez-Fidalgo A.; Vieites B.; Romero I.; Palacios J.

    Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 51 84-96. .

    [doi:10.1016/j.patol.2017.11.002]

  • Santaballa, A; Matias-Guiu, X; Redondo, A; Carballo, N; Gil, M; Gomez, C; Gorostidi, M; Gutierrez, M; Gonzalez-Martin, A

    SEOM clinical guidelines for endometrial cancer (2017)

    CLINICAL & TRANSLATIONAL ONCOLOGY 20 29-37. .

    [doi:10.1007/s12094-017-1809-9]

  • Eritja, N; Jove, M; Fasmer, KE; Gatius, S; Portero-Otin, M; Trovik, J; Krakstad, C; Sol, J; Pamplona, R; Haldorsen, IS; Matias-Guiu, X

    Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients

    Oncotarget 8 109018-109026. .

    [doi:10.18632/oncotarget.22558]

  • Depreeuw, J; Stelloo, E; Osse, EM; Creutzberg, CL; Nout, RA; Moisse, M; Garcia-Dios, DA; Dewaele, M; Willekens, K; Marine, JC; Matias-Guiu, X; Amant, F; Lambrechts, D; Bosse, T

    Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma

    CLINICAL CANCER RESEARCH 23 7232-7241. .

    [doi:10.1158/1078-0432.CCR-17-0566]

  • Martinez-Garcia, E; Lesur, A; Devis, L; Cabrera, S; Matias-Guiu, X; Hirschfeld, M; Asberger, J; van Oostrum, J; Casares de Cal MLÁ; Gomez-Tato, A; Reventos, J; Domon, B; Colas, E; Gil-Moreno, A

    Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment

    CLINICAL CANCER RESEARCH 23 6458-6467. .

    [doi:10.1158/1078-0432.CCR-17-0474]

  • Garrido, P; Aldaz, A; Calleja, MA; de Alava, E; Lamas, MJ; Martin, M; Matias-Guiu, X; Palacios, J; Vera, R

    Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 41 688-691. .

    [doi:10.7399/fh.10877]

  • Le Gallo, M; Rudd, ML; Urick, ME; Hansen, NF; Zhang, S; NISC Comparative Sequencing Program; Lozy F; Sgroi DC; Vidal Bel A; Matias-Guiu X; Broaddus RR; Lu KH; Levine DA; Mutch DG; Goodfellow PJ; Salvesen HB; Mullikin JC; Bell DW

    Somatic Mutation Profiles of Clear Cell Endometrial Tumors Revealed by Whole Exome and Targeted Gene Sequencing

    CANCER 123 3261-3268. .

    [doi:10.1002/cncr.30745]

  • Novell, A; Morales, S; Valls J; Panades, MJ; Salud, A; Iglesias, E; Vilardell, F; Matias-Guiu, X; Llombart-Cussac, A

    Novel biomarkers in primary breast core biopsies to predict poor response to neoadjuvant chemotherapy and appearance of metastases

    HISTOLOGY AND HISTOPATHOLOGY 32 909-915. .

    [doi:10.14670/HH-11-849]

  • Altadill, T; Dowdy, TM; Gill, K; Reques, A; Menon, SS; Moiola, CP; Lopez-Gil, C; Coll, E; Matias-Guiu, X; Cabrera, S; Garcia, A; Reventos, J; Byers, SW; Gil-Moreno, A; Cheema, AK; Colas, E

    Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis

    SCIENTIFIC REPORTS 7 8803-8803. .

    [doi:10.1038/s41598-017-09169-2]

Proyectos

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment